Vision Infra Equipment Solutions Limited (NSE:VIESL)
India flag India · Delayed Price · Currency is INR
166.00
-2.90 (-1.72%)
At close: Aug 1, 2025

Sage Therapeutics Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
340.52266.8991.8992.7951.42
Depreciation & Amortization
549.91423.61336.54219.49160.27
Loss (Gain) From Sale of Assets
-43.37-154.16-88.86-92.65-38.02
Other Operating Activities
241.11170.25160.6104.1775.91
Change in Accounts Receivable
-515.41-509.03-0.53-164.28-124.27
Change in Inventory
-124.62-193.3674.93-109.38114.75
Change in Accounts Payable
-94.2179.13-12.9284.06-50.59
Change in Other Net Operating Assets
45.09-65.93199.8240.78113.44
Operating Cash Flow
399.0218.16761.46174.98302.91
Operating Cash Flow Growth
2097.27%-97.61%335.16%-42.23%-
Capital Expenditures
-1,533-577.98-730.97-465.44-545.02
Sale of Property, Plant & Equipment
217.78----
Other Investing Activities
-67.72-33.36-27.57-5.8-72.58
Investing Cash Flow
-1,383-607.94-757.14-476.28-623.17
Short-Term Debt Issued
-247.68106.22153.37278.37
Long-Term Debt Issued
183.64675.26100.14226.25180.23
Total Debt Issued
183.64922.94206.36379.62458.6
Net Debt Issued (Repaid)
183.64922.94206.36379.62458.6
Issuance of Common Stock
1,176----
Other Financing Activities
-370.5-301.75-193.51-109.11-91.4
Financing Cash Flow
989.29621.1912.85270.51367.2
Miscellaneous Cash Flow Adjustments
----0-
Net Cash Flow
5.431.417.16-30.7946.94
Free Cash Flow
-1,134-559.8230.48-290.46-242.11
Free Cash Flow Margin
-25.58%-16.82%0.85%-9.86%-15.31%
Free Cash Flow Per Share
-53.18-32.361.76-16.79-13.99
Cash Interest Paid
272.47166.21147.06105.6180.34
Cash Income Tax Paid
166.92125.0960.6733.4125.89
Levered Free Cash Flow
-1,462-712.42-104.04-386.25-
Unlevered Free Cash Flow
-1,292-608.54-10.16-319.21-
Change in Net Working Capital
708.79704.24-242.86152.69-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.